Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 10/20 | 0.52 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.50 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2875670 | 0.89 | TP53 (0.65) | TP53KCNH2NR4A1KMT2AMAPT | |
| SCHEMBL20158110 | 0.86 | MDM2 (0.46) | TP53KCNH2SRD5A2NR4A1KMT2A | |
| SCHEMBL28039223 | 0.85 | MAPT (0.68) | KCNH2KMT2AMAPK1RAB9AMAPT | |
| SCHEMBL10599055 | 0.85 | SRD5A2 (0.54) | TP53SRD5A2NR4A1KMT2AMAPK1 | |
| SCHEMBL9280669 | 0.82 | POLB (0.71) | KCNH2KMT2AMAPK1RAB9AMAPT | |
| SCHEMBL9281265 | 0.81 | NR4A1 (0.65) | TP53SRD5A2NR4A1KMT2AMAPK1 | |
| SCHEMBL29928911 | 0.81 | NR4A1 (0.65) | TP53SRD5A2NR4A1KMT2AMAPK1 | |
| SCHEMBL7466437 | 0.80 | ALDH1A1 (0.61) | TP53SRD5A2NR4A1KMT2AMAPK1 | |
| SCHEMBL9779330 | 0.78 | CA1 (0.62) | TP53KCNH2SRD5A2NR4A1KMT2A | |
| SCHEMBL5022620 | 0.78 | ALDH1A1 (0.53) | TP53SRD5A2MAPK1RAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3539960-A1 | NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) | 2019-09-18 | — | — | EP | disclosed |